SCHEMBL9511248

SCHEMBL9511248

CNC(C)CN1CCCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
CARM1 Q86X55 1/20 0.41
PRMT6 Q96LA8 1/20 0.41
PRMT8 Q9NR22 1/20 0.41
MAPT P10636 2/20 0.39
ATM Q13315 1/20 0.39
ANPEP P15144 1/20 0.38
ERAP2 Q6P179 1/20 0.38
LTA4H P09960 1/20 0.35
ALDH1A1 P00352 2/20 0.33
CHRM2 P08172 2/20 0.33
ADRA2B P18089 2/20 0.33
DRD3 P35462 2/20 0.33
SIGMAR1 Q99720 2/20 0.33
HRH3 Q9Y5N1 2/20 0.33
HPGD P15428 1/20 0.33
LMNA P02545 2/20 0.33
HSD17B10 Q99714 1/20 0.32
NCF1 P14598 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9511251 1.00 KMT2A (0.42) KMT2AMEN1CARM1PRMT6PRMT8
SCHEMBL7342935 1.00 KMT2A (0.42) KMT2AMEN1CARM1PRMT6PRMT8
SCHEMBL25575441 0.98 MEN1 (0.46) KMT2AMEN1CARM1PRMT6PRMT8
SCHEMBL17424103 0.98 MEN1 (0.46) KMT2AMEN1CARM1PRMT6PRMT8
SCHEMBL8337259 0.81 GAA (0.39) MAPTALDH1A1SIGMAR1
SCHEMBL27015205 0.80 KMT2A (0.42) KMT2AMEN1CARM1PRMT6PRMT8
SCHEMBL16316628 0.79 USP2 (0.50) KMT2AMEN1MAPTANPEPALDH1A1
SCHEMBL19919871 0.79 USP2 (0.50) KMT2AMEN1MAPTANPEPALDH1A1
SCHEMBL17424098 0.78 MEN1 (0.46) KMT2AMEN1CARM1PRMT6PRMT8
SCHEMBL18461939 0.78 MEN1 (0.41) KMT2AMEN1CARM1PRMT6PRMT8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3833662-B1 INHIBITORS OF KEAP1-NRF2 PROTEIN-PROTEIN INTERACTION JANSSEN PHARMACEUTICA NV (BE) 2024-01-17 EP disclosed
WO-2020041169-A2 INHIBITORS OF KEAP1-NRF2 PROTEIN-PROTEIN INTERACTION JANSSEN PHARMACEUTICA NV (BE) 2020-02-27 WO disclosed
WO-2016020200-A1 NITROGEN-CONTAINING COMPOUNDS SUITABLE FOR USE IN THE PRODUCTION OF POLYURETHANES EVONIK DEGUSSA GMBH (DE) 2016-02-11 WO disclosed
EP-0254545-B1 DIAMINE COMPOUNDS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-10-06 EP disclosed
EP-0254545-A2 Diamine compounds IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1988-01-27 EP disclosed